Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request

Keratinocytes Present Staphylococcus aureus Enterotoxins and Promote Malignant and Nonmalignant T Cell Proliferation in Cutaneous T-Cell Lymphoma.

Item request has been placed! ×
Item request cannot be made. ×
loading   Processing Request
  • Additional Information
    • Publication Date:
      2024
    • Collection:
      Université de Lausanne (UNIL): Serval - Serveur académique lausannois
    • Abstract:
      Cutaneous T-cell lymphoma is characterized by malignant T cells proliferating in a unique tumor microenvironment dominated by keratinocytes (KCs). Skin colonization and infection by Staphylococcus aureus are a common cause of morbidity and are suspected of fueling disease activity. In this study, we show that expression of HLA-DRs, high-affinity receptors for staphylococcal enterotoxins (SEs), by KCs correlates with IFN-γ expression in the tumor microenvironment. Importantly, IFN-γ induces HLA-DR, SE binding, and SE presentation by KCs to malignant T cells from patients with Sézary syndrome and malignant and nonmalignant T-cell lines derived from patients with Sézary syndrome and mycosis fungoides. Likewise, preincubation of KCs with supernatant from patient-derived SE-producing S aureus triggers proliferation in malignant T cells and cytokine release (including IL-2), when cultured with nonmalignant T cells. This is inhibited by pretreatment with engineered bacteriophage S aureus-specific endolysins. Furthermore, alteration in the HLA-DR-binding sites of SE type A and small interfering RNA-mediated knockdown of Jak3 and IL-2Rγ block induction of malignant T-cell proliferation. In conclusion, we show that upon exposure to patient-derived S aureus and SE, KCs stimulate IL-2Rγ/Jak3-dependent proliferation of malignant and nonmalignant T cells in an environment with nonmalignant T cells. These findings suggest that KCs in the tumor microenvironment play a key role in S aureus-mediated disease activity in cutaneous T-cell lymphoma.
    • File Description:
      application/pdf
    • Relation:
      info:eu-repo/semantics/altIdentifier/pmid/38762064; info:eu-repo/semantics/altIdentifier/eissn/1523-1747; info:eu-repo/semantics/altIdentifier/urn/urn:nbn:ch:serval-BIB_96839F5A82570; https://serval.unil.ch/notice/serval:BIB_96839F5A8257; https://serval.unil.ch/resource/serval:BIB_96839F5A8257.P001/REF.pdf
    • Accession Number:
      10.1016/j.jid.2024.04.018
    • Online Access:
      https://serval.unil.ch/notice/serval:BIB_96839F5A8257
      https://doi.org/10.1016/j.jid.2024.04.018
      https://serval.unil.ch/resource/serval:BIB_96839F5A8257.P001/REF.pdf
      http://nbn-resolving.org/urn/resolver.pl?urn=urn:nbn:ch:serval-BIB_96839F5A82570
    • Rights:
      info:eu-repo/semantics/openAccess ; CC BY-NC-ND 4.0 ; https://creativecommons.org/licenses/by-nc-nd/4.0/
    • Accession Number:
      edsbas.20C70AD8